SMV Thrombosis on Taking Oral Contraceptive with Protein C and Protein S Deficiency.
- Author:
Min Seok YEO
1
;
Yong Sun KWON
;
Seok Ho CHOI
;
Ki Hong KIM
;
Chang Gyoo BYUN
;
Young Taeg KOH
;
Dong Youb SUH
;
Hyo Jin LEE
Author Information
1. Department of Surgery, National Police Hospital, Seoul, Korea. choish69@hotmail.com
- Publication Type:Case Report
- Keywords:
Mesenteric venous thrombosis;
Hypercoagulable;
Oral contraceptive
- MeSH:
Adult;
Antithrombin III;
Contraceptives, Oral;
Factor VIII;
Female;
Humans;
Hypertension, Portal;
Ischemia;
Protein C*;
Protein S Deficiency*;
Protein S*;
Prothrombin;
Risk Factors;
Short Bowel Syndrome;
Thrombosis*;
Venous Thrombosis
- From:Journal of the Korean Surgical Society
2006;71(3):222-225
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Mesenteric venous thrombosis (MVT) is uncommon, but it is often aggravated to a lethal form of intestinal ischemia. Multiple risk factors are associated with mesenteric venous thrombosis, including hypercoagulable or inflammatory states, previous abdominal surgery, abdominal trauma, portal hypertension and oral contraceptives. The use of estrogen-containing oral contraceptives accounts for 4% to 5% of all the cases of MVT. Oral contraceptives have been reported to decrease antithrombin III, increase the levels of prothrombin complex factor and factor VIII, and to inhibit the fibrinolytic system. We describe here a case of 42-year-old woman who had taken oral contraceptives for 7 years and she was diagnosed to have Protein C and Protein S deficiency, and superior mesenteric venous (SMV) and portal vein thrombosis. She underwent segmental resection of the small bowel. She was later discharged without suffering with short bowel syndrome or any other complications.
